261 related articles for article (PubMed ID: 30386115)
1. Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives.
Boussios S; Moschetta M; Karathanasi A; Tsiouris AK; Kanellos FS; Tatsi K; Katsanos KH; Christodoulou DK
Ann Gastroenterol; 2018; 31(6):659-669. PubMed ID: 30386115
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations.
Enomoto LM; Shen P; Levine EA; Votanopoulos KI
Cancer Manag Res; 2019; 11():4231-4241. PubMed ID: 31190990
[TBL] [Abstract][Full Text] [Related]
3. Malignant peritoneal mesothelioma: a review.
Kim J; Bhagwandin S; Labow DM
Ann Transl Med; 2017 Jun; 5(11):236. PubMed ID: 28706904
[TBL] [Abstract][Full Text] [Related]
4. Malignant peritoneal mesothelioma: a review.
Broeckx G; Pauwels P
Transl Lung Cancer Res; 2018 Oct; 7(5):537-542. PubMed ID: 30450291
[TBL] [Abstract][Full Text] [Related]
5. Malignant peritoneal mesothelioma literature review: past, present, and future.
Gregory SN; Sarvestani AL; Blakely AM
Dig Med Res; 2022 Jun; 5():. PubMed ID: 36061260
[TBL] [Abstract][Full Text] [Related]
6. Diffuse malignant peritoneal mesothelioma: A review.
Sun L; Li C; Gao S
Front Surg; 2022; 9():1015884. PubMed ID: 36684194
[TBL] [Abstract][Full Text] [Related]
7. Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival.
Sugarbaker PH; Chang D
Eur J Surg Oncol; 2017 Jul; 43(7):1228-1235. PubMed ID: 28189456
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Malignant Peritoneal Mesothelioma.
Levý M; Boublíková L; Büchler T; Šimša J
Klin Onkol; 2019; 32(5):333-337. PubMed ID: 31610664
[TBL] [Abstract][Full Text] [Related]
9. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma.
Tan GH; Cheung M; Chanyaputhipong J; Soo KC; Teo MC
Ann Acad Med Singap; 2013 Jun; 42(6):291-6. PubMed ID: 23842770
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma.
Kusamura S; Baratti D; De Simone M; Pasqual EM; Ansaloni L; Marrelli D; Robella M; Accarpio F; Valle M; Scaringi S; Biacchi D; Palopoli C; Gazzanelli S; Guaglio M; Deraco M
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765620
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and management of patients with malignant peritoneal mesothelioma.
Alexander HR; Burke AP
J Gastrointest Oncol; 2016 Feb; 7(1):79-86. PubMed ID: 26941986
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal mesothelioma.
Greenbaum A; Alexander HR
Transl Lung Cancer Res; 2020 Feb; 9(Suppl 1):S120-S132. PubMed ID: 32206577
[TBL] [Abstract][Full Text] [Related]
13. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
14. Lurbinectedin in Refractory Diffuse Malignant Peritoneal Mesothelioma: Report of Two Cases.
Gros L; Szturz P; Diciolla A; Kirchner V; Peters S; Schaefer N; Hubner M; Digklia A
Front Oncol; 2021; 11():704295. PubMed ID: 34222029
[TBL] [Abstract][Full Text] [Related]
15. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma and predictors of survival.
Gilani SNS; Mehta A; Garcia-Fadrique A; Rowaiye B; Jenei V; Dayal S; Chandrakumaran K; Carr N; Mohamed F; Cecil T; Moran B
Int J Hyperthermia; 2018 Aug; 34(5):578-584. PubMed ID: 29431036
[TBL] [Abstract][Full Text] [Related]
17. Malignant Peritoneal Mesothelioma Mimicking Recurrent Diverticulitis.
Robalino Gonzaga ES; Guzman Rojas P; Vanar V
Cureus; 2019 Jan; 11(1):e3906. PubMed ID: 30915265
[TBL] [Abstract][Full Text] [Related]
18. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives.
Spiliotis J; Halkia E; de Bree E
Curr Oncol; 2016 Jun; 23(3):e266-75. PubMed ID: 27330364
[TBL] [Abstract][Full Text] [Related]
19. [Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia].
Gómez Portilla A; Cendoya I; Muriel J; Olabarria I; Guede N; Moraza N; Fernández E; Martínez de Lecea C; Magrach L; Martín E; Romero E; Aguado I; Valdovinos M; Larrabide I
Cir Esp; 2007 Feb; 81(2):82-6. PubMed ID: 17306123
[TBL] [Abstract][Full Text] [Related]
20. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy.
Yan TD; Haveric N; Carmignani CP; Chang D; Sugarbaker PH
Cancer; 2005 Feb; 103(4):839-49. PubMed ID: 15637690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
